EMJ GOLD - European Medical Journal

This site is intended for healthcare professionals

Continue

Pharma News, Views & Analysis

Filter Advertise With Us
Coins falling

ABPI report highlights decline in UK pharma investment

The latest ABPI and PwC Pharmaceutical Competitiveness Framework reveals the UK is losing ground in pharma R&D, investment, and clinical trials, with rankings slipping sharply since 2018.

Novo Nordisk cuts jobs to fund diabetes and obesity growth

Novo Nordisk announces 9,000 job cuts to streamline operations and reinvest in diabetes and obesity growth, aiming for long-term efficiency.

Lilly's TuneLab to share AI models with small biotechs

Lilly has launched TuneLab, giving biotech companies access to AI-powered drug discovery models based on over £1bn in research investment.

MSD strikes $10bn deal for Verona Pharma

MSD has agreed to acquire UK biopharma company Verona Pharma in a $10bn deal, strengthening its cardio-pulmonary care portfolio.

Rising STEM stars take home Thermo Fisher Award

A group of 300 middle schoolers are named in the 2025 Thermo Fisher Junior Innovators Challenge for STEM projects in AI to climate change.

Newcastle University wins £22m UK's NIHR health tech award

The National Institute for Health and Care Research (NIHR) is funding Newcastle Univeristy’s work in emerging diagnostics, devices and more.
British government buildings

UK government establishes RNA Biofoundry

A £29.6 million government investment will establish the UK RNA Biofoundry in Darlington, providing manufacturing capacity to accelerate RNA therapies from lab to clinic.
A collection of illustrated lab equipment

Novo Nordisk taps Replicate’s srRNA platform for obesity

Novo Nordisk partners with Replicate Bioscience in a $550M srRNA deal to develop new therapies for obesity, diabetes and cardiometabolic diseases.
We’ve noticed you’re accessing
from North/South America.